Skip to content

Clinical study of infants with diarrhea Bifidobacterium BB-12 treatment

Clinical study of infants with diarrhea Bifidobacterium BB-12 treatment

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IIR-15007550
Enrollment
Unknown
Registered
2015-11-30
Start date
2015-12-08
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diarrhea

Interventions

one:Bifidobacterium BB-12
two:MAMIAI
three:Placebo

Sponsors

First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 3 Years

Inclusion criteria

Inclusion criteria: 1. healthy children aged 3 years of age; 2. meet the diagnostic criteria for diarrhea: stool changed (water will dilute form, paste it, mucus blood and pus) and stool frequency more than usual; 3. diarrhea no more than two days; 4. not used within two weeks of probiotics as therapeutic purposes; 5. no milk allergy or intolerance; 6. no immunodeficiency, chronic gastrointestinal disease or chronic diarrhea and malnutrition; 7. No oral rotavirus vaccine or polio vaccine within a month.

Exclusion criteria

Exclusion criteria: 1. children relevant examinations or treatment is not complete; 2. parents or children with poor compliance, the treatment process does not cooperate with treatment, can not judge the efficacy of persons; 3. children with serious complications, such as severe dehydration, shock, and pneumonia.

Design outcomes

Primary

MeasureTime frame
Then routine, they train, stool smear test;Analysis of fecal flora;

Countries

China

Contacts

Public ContactZhaoxia Wang
wangzhaoxia1969@163.com+86 13756665090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026